Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Haematological and immunological characteristics of eastern hellbenders (Cryptobranchus alleganiensis alleganiensis) infected and co-infected with endo- and ectoparasites.

Hopkins WA, Fallon JA, Beck ML, Coe BH, Jachowski CM.

Conserv Physiol. 2016 Mar 21;4(1):cow002. doi: 10.1093/conphys/cow002. eCollection 2016.

2.

Malaria endemicity and co-infection with tissue-dwelling parasites in Sub-Saharan Africa: a review.

Onkoba NW, Chimbari MJ, Mukaratirwa S.

Infect Dis Poverty. 2015 Aug 29;4:35. doi: 10.1186/s40249-015-0070-0. Review.

3.

From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.

Mpanya A, Hendrickx D, Baloji S, Lumbala C, da Luz RI, Boelaert M, Lutumba P.

PLoS Negl Trop Dis. 2015 Apr 9;9(4):e0003686. doi: 10.1371/journal.pntd.0003686. eCollection 2015 Apr.

4.

Clinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.

Kato CD, Nanteza A, Mugasa C, Edyelu A, Matovu E, Alibu VP.

PLoS One. 2015 Feb 26;10(2):e0118370. doi: 10.1371/journal.pone.0118370. eCollection 2015.

5.

Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Nagle AS, Khare S, Kumar AB, Supek F, Buchynskyy A, Mathison CJ, Chennamaneni NK, Pendem N, Buckner FS, Gelb MH, Molteni V.

Chem Rev. 2014 Nov 26;114(22):11305-47. doi: 10.1021/cr500365f. Epub 2014 Nov 3. Review. No abstract available.

6.

Diagnostic work-up of neurological syndromes in a rural African setting: knowledge, attitudes and practices of health care providers.

Mpanya A, Boelaert M, Baloji S, Matangila J, Lubanza S, Bottieau E, Chappuis F, Lutumba P, Hendrickx D.

PLoS One. 2014 Oct 23;9(10):e110167. doi: 10.1371/journal.pone.0110167. eCollection 2014.

7.

Treatment options for second-stage gambiense human African trypanosomiasis.

Eperon G, Balasegaram M, Potet J, Mowbray C, Valverde O, Chappuis F.

Expert Rev Anti Infect Ther. 2014 Nov;12(11):1407-17. doi: 10.1586/14787210.2014.959496. Epub 2014 Sep 10. Review.

8.

In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.

Wenzler T, Yang S, Patrick DA, Braissant O, Ismail MA, Tidwell RR, Boykin DW, Wang MZ, Brun R.

Antimicrob Agents Chemother. 2014 Aug;58(8):4452-63. doi: 10.1128/AAC.02309-13. Epub 2014 May 27.

9.

A mixed methods study of a health worker training intervention to increase syndromic referral for gambiense human African trypanosomiasis in South Sudan.

Palmer JJ, Surur EI, Checchi F, Ahmad F, Ackom FK, Whitty CJ.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2742. doi: 10.1371/journal.pntd.0002742. eCollection 2014 Mar.

10.

Imaging African trypanosomes.

MacLean L, Myburgh E, Rodgers J, Price HP.

Parasite Immunol. 2013 Sep-Oct;35(9-10):283-94. doi: 10.1111/pim.12046. Review.

11.

Syndromic algorithms for detection of gambiense human African trypanosomiasis in South Sudan.

Palmer JJ, Surur EI, Goch GW, Mayen MA, Lindner AK, Pittet A, Kasparian S, Checchi F, Whitty CJ.

PLoS Negl Trop Dis. 2013;7(1):e2003. doi: 10.1371/journal.pntd.0002003. Epub 2013 Jan 17.

12.

The use of Loop-mediated Isothermal Amplification (LAMP) to detect the re-emerging Human African Trypanosomiasis (HAT) in the Luangwa and Zambezi valleys.

Namangala B, Hachaambwa L, Kajino K, Mweene AS, Hayashida K, Simuunza M, Simukoko H, Choongo K, Chansa P, Lakhi S, Moonga L, Chota A, Ndebe J, Nsakashalo-Senkwe M, Chizema E, Kasonka L, Sugimoto C.

Parasit Vectors. 2012 Dec 4;5:282. doi: 10.1186/1756-3305-5-282.

13.

In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.

Schmid C, Kuemmerle A, Blum J, Ghabri S, Kande V, Mutombo W, Ilunga M, Lumpungu I, Mutanda S, Nganzobo P, Tete D, Mubwa N, Kisala M, Blesson S, Mordt OV.

PLoS Negl Trop Dis. 2012;6(11):e1920. doi: 10.1371/journal.pntd.0001920. Epub 2012 Nov 29.

14.

Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan.

Checchi F, Cox AP, Chappuis F, Priotto G, Chandramohan D, Haydon DT.

Parasit Vectors. 2012 Aug 7;5:157. doi: 10.1186/1756-3305-5-157.

15.

Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?

Ruiz-Postigo JA, Franco JR, Lado M, Simarro PP.

PLoS Negl Trop Dis. 2012;6(5):e1541. doi: 10.1371/journal.pntd.0001541. Epub 2012 May 29. Review.

16.

New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants.

Seke Etet PF, Mahomoodally MF.

ScientificWorldJournal. 2012;2012:343652. doi: 10.1100/2012/343652. Epub 2012 Apr 19.

17.

Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot study.

Njamnshi AK, Seke Etet PF, Perrig S, Acho A, Funsah JY, Mumba D, Muyembe JJ, Kristensson K, Bentivoglio M.

PLoS Negl Trop Dis. 2012;6(2):e1525. doi: 10.1371/journal.pntd.0001525. Epub 2012 Feb 14.

18.

Sleeping sickness in travelers - do they really sleep?

Urech K, Neumayr A, Blum J.

PLoS Negl Trop Dis. 2011 Nov;5(11):e1358. doi: 10.1371/journal.pntd.0001358. Epub 2011 Nov 1.

19.

Prevalence and types of coinfections in sleeping sickness patients in kenya (2000/2009).

Kagira JM, Maina N, Njenga J, Karanja SM, Karori SM, Ngotho JM.

J Trop Med. 2011;2011:248914. doi: 10.1155/2011/248914. Epub 2011 Sep 11.

20.

Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.

Kuepfer I, Hhary EP, Allan M, Edielu A, Burri C, Blum JA.

PLoS Negl Trop Dis. 2011 Mar 1;5(3):e968. doi: 10.1371/journal.pntd.0000968.

Items per page

Supplemental Content

Write to the Help Desk